drugset
Drugs / Autologous CMV-specific CTL
last change Mar 2012 re-read 3 minutes ago

Autologous CMV-specific CTL

Cell therapy

Developed for
brain cancer · glioblastoma
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

Trials 1

today NCT01205334 · Ph 1/2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01205334 Nov 2010 → Jan 2012 brain cancer, glioblastoma Baylor College of Medicine Terminated No outcome recorded Stop: Enrollment

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous CMV-specific CTL ClinicalTrials.gov intervention name — accepted as the source's own label NCT01205334 ↗
Action Deplete “kill cells with CMV on their surface” NCT01205334 ↗
Modality Cell therapy “special immune cells” NCT01205334 ↗
Route Intravenous “given by intravenous injection” NCT01205334 ↗